CBY1 and chronic myelogenous leukemia, BCR-ABL1 positive: CBY1 participation in the constitutive activation of β-catenin in CML was suggested by our recent study showing that a significant reduction in CBY1 expression levels is associated with BCR-ABL1 and correlates with nuclear b catenin increment [18].